| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Jack Welch--Success Is Getting Back Up on the Horse |
|
Advice You - Jack Welch--Success Is Getting Back Up on the Horse
A few months ago I had the opportunity to spend a few minutes with Jack Welch, past CEO of GE. A fan According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product tastic opportunity. Some of the things he said about who they hire and what they are looking for in ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in managers sort of hit home with what I am telling clients, and what I am telling my teen leadership g lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. oup (our Rising Stars program). The Best Managers Aren't Perfect But They Keep Getting Back on t here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe e Horse Jack Welch--"We look for people that are not perfect. People that have made mistakes, b d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro t know how to quickly get back up on the horse when they've been thrown off, and those that turn the ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc loss around into a win. It isn't about never making mistakes, it's about getting back up and moving easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi orward toward the results. If someone has never experienced falling off and shown their ability to g nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically t back up they might not be the managers we want." "Leadership is about results, not experience, no and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ education, or any of the other things that everyone claims is leadership. It's about
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi e to consistantly deliver results,
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a geting right back on until you ultimately deliver results." That's so in line with what I keep tel dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ing my clients and my youth leadership groups I work with. The path to your destination is almost ne cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin er a straight line. There will be zig zags, side trips, and steps backward. Too many people slip of tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen the trail, and just walk away telling themselves they just failed. The winners are the ones that le t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel rn from what took them off the trail, figure out how to get back on the trail, and keep steadily plo ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ding toward the goal even with the setbacks. Failure Is a Choice--Choose to Win You only fa y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products l one time--when you say you have....and QUIT. When that happens there is only one guaranteed outco . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de e--Failure. That makes failure a choice. Those that choose to not get back on choose to be victims. elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip Those that win choose to get back on the horse, get back on the trail and plod along toward the goal tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Dumping the Cubicle Life - 10 Reasons to Start Your Own Business About Mileage Correction And Adjustment Advice for Purchasing Renters Insurance
|